.
.. he wasn't certain, though, how much he'd be able to work before then.
.
.
chemotherapy involved two hours at the hospital every other week. he'd leave wearing a fanny pack that would continue to deliver treatment for 48 straight hours, one slow drip at a time.
.
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
.
. may 17, 2018
.
.